SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001493152-18-007274
Filing Date
2018-05-16
Accepted
2018-05-16 14:05:22
Documents
1
Period of Report
2018-03-31
Effectiveness Date
2018-05-16

Document Format Files

Seq Description Document Type Size
1 formnt10q.htm NT 10-Q 25693
  Complete submission text file 0001493152-18-007274.txt   26992
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 000-55453 | Film No.: 18839602
SIC: 2834 Pharmaceutical Preparations